- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00737399
Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)
April 22, 2026 updated by: Dawson Church, Soul Medicine Institute
Anxiety and depression have been found to be significant co-occurring conditions in cancer patients.
This study examines these and other psychological conditions in patients diagnosed with cholangiocarcinoma, a rare cancer of the bile duct, with an average survival time of three to six months post-diagnosis.
Participants are taught EFT in telephone and internet group coaching sessions, and have access to an online support forum.
They complete the Mini-Mental Adjustment to Cancer Scale (Mini-MAC), EORTC Quality of Life scale, the PTSD checklist, the Patient Health Questionnaire, and a brief health checklist.
Participants also provide medical records confirming their diagnosis, and markers, both before and after the study.
The study is expected to enroll 20-15 cholangiocarcinoma patients, and use a within-subjects, time series, repeated measures design.
Symptoms are assessed prior to coaching, after four, and again after eight weekly coaching sessions.
Follow-ups will occur in one month, three months, and one year.
It is hypothesized that a drop in the severity of co-occurring psychological symptoms, pain and insomnia may occur after EFT coaching.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
14
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Santa Rosa, California, United States, 95403
- Soul Medicine Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of cholangiocarcinoma
- Ability to complete forms and attend phone coaching sessions
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Lifestyle Counseling with Emotional Freedom Techniques (EFT)
|
Two series of four sessions of phone support group coaching instruction in the use of EFT
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
depression
Time Frame: duration of study
|
duration of study
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
anxiety
Time Frame: duration of study
|
duration of study
|
|
pain
Time Frame: duration of study
|
duration of study
|
|
insomnia
Time Frame: duration of study
|
duration of study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dawson Church, PhD, Soul Medicine Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 20, 2008
Primary Completion (Estimated)
April 23, 2028
Study Completion (Estimated)
December 25, 2028
Study Registration Dates
First Submitted
August 18, 2008
First Submitted That Met QC Criteria
August 18, 2008
First Posted (Estimated)
August 19, 2008
Study Record Updates
Last Update Posted (Actual)
April 27, 2026
Last Update Submitted That Met QC Criteria
April 22, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Behavioral Symptoms
- Neoplasms by Histologic Type
- Neoplasms, Glandular and Epithelial
- Adenocarcinoma
- Sleep Wake Disorders
- Carcinoma
- Sleep Disorders, Intrinsic
- Dyssomnias
- Pathological Conditions, Signs and Symptoms
- Behavior
- Signs and Symptoms
- Pain
- Neoplasms
- Anxiety Disorders
- Depression
- Sleep Initiation and Maintenance Disorders
- Cholangiocarcinoma
Other Study ID Numbers
- SMI-CHOL-82008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
Clinical Trials on Lifestyle Counseling with Emotional Freedom Techniques (EFT)
-
Soul Medicine InstituteCompletedStress Disorders, Post-TraumaticUnited States
-
Marmara UniversityActive, not recruiting
-
Istanbul University-CerrahpasaCompleted
-
Soul Medicine InstituteCompletedStress Disorders, Post-TraumaticUnited States
-
Soul Medicine InstituteCompletedStress Disorders, Post-TraumaticUnited States
-
Soul Medicine InstituteTel Aviv UniversityCompleted
-
Soul Medicine InstituteCompletedStress Disorders, Post-TraumaticUnited States
-
Soul Medicine InstituteCompleted
-
Bingol UniversityActive, not recruitingCesarean Section | Preoperative AnxietyTurkey (Türkiye)
-
Hatice BalcıNot yet recruitingCoronary Artery Bypass Graft (CABG) | Effects of Emotional Freedom Techniques (EFT)Turkey (Türkiye)